國立高雄大學圖資館 |

Language: English

Back

Utilizing effective risk communicati...

Lazris, Andy.

Utilizing effective risk communication in COVID-19highlighting the BRCT /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Utilizing effective risk communication in COVID-19by Andy Lazris, Erik Rifkin.
Reminder of title:	highlighting the BRCT /
Author:	Lazris, Andy.
other author:	Rifkin, Erik.
Published:	Cham :Springer International Publishing :2021.
Description:	xv, 131 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Health risk communication.
Online resource:	https://doi.org/10.1007/978-3-030-74521-9
ISBN:	9783030745219

Utilizing effective risk communication in COVID-19highlighting the BRCT /
Lazris, Andy.

Utilizing effective risk communication in COVID-19highlighting the BRCT /[electronic resource] :by Andy Lazris, Erik Rifkin. - Cham :Springer International Publishing :2021. - xv, 131 p. :ill., digital ;24 cm.

PART I: Communicating Risk and Benefit in the Medical Community -- Patients, Doctors and Decision-making -- Absolute and Relative Risks -- Communicating health risks to patients and the public -- Erik's Recent Experience with Doctors and a Heart Attack -- Why not all numbers are the same -- Putting BRCTs to use in helping people understand health outcomes -- PART II: Videos to Describe the Utility of BRCTs -- PART III: COVID-19 Communication -- Segue to Part III: BRCTs & COVID-19 -- How important are the number of cases? -- The demographics of COVID-19 -- Why COVID-19 Should Not Have Prevented Colleges (and Elementary and Secondary Schools) from Opening Last Fall -- Nursing homes, the nidus of COVID-19 death -- The use of universal masking -- Communicating about the impact of surges and quarantines -- Communicating about the adverse effects of the cure -- How we communicate about COVID-19 in other countries -- Other viral pandemics with reference to COVID-19 -- A Path Forward: BRCTs for COVID-19 and Beyond.

ISBN: 9783030745219

Standard No.: 10.1007/978-3-030-74521-9doiSubjects--Topical Terms:

338510
Health risk communication.

LC Class. No.: RA423.2 / .L39 2021

Dewey Class. No.: 362.1014

Utilizing effective risk communication in COVID-19highlighting the BRCT /
LDR:02004nmm a2200313 a 4500 001 608200
003 DE-He213
005 20210813110839.0
006 m d
007 cr nn 008maaau
008 220119s2021 sz s 0 eng d
020 $a 9783030745219 $q (electronic bk.)
020 $a 9783030745202 $q (paper)
024 7 $a 10.1007/978-3-030-74521-9 $2 doi
035 $a 978-3-030-74521-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RA423.2 $b .L39 2021
072 7 $a MMKL $2 bicssc
072 7 $a MED015000 $2 bisacsh
072 7 $a MKPL $2 thema
082 0 4 $a 362.1014 $2 23
090 $a RA423.2 $b .L431 2021
100 1 $a Lazris, Andy. $3 905531
245 1 0 $a Utilizing effective risk communication in COVID-19 $h [electronic resource] : $b highlighting the BRCT / $c by Andy Lazris, Erik Rifkin.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xv, 131 p. : $b ill., digital ; $c 24 cm.
505 0 $a PART I: Communicating Risk and Benefit in the Medical Community -- Patients, Doctors and Decision-making -- Absolute and Relative Risks -- Communicating health risks to patients and the public -- Erik's Recent Experience with Doctors and a Heart Attack -- Why not all numbers are the same -- Putting BRCTs to use in helping people understand health outcomes -- PART II: Videos to Describe the Utility of BRCTs -- PART III: COVID-19 Communication -- Segue to Part III: BRCTs & COVID-19 -- How important are the number of cases? -- The demographics of COVID-19 -- Why COVID-19 Should Not Have Prevented Colleges (and Elementary and Secondary Schools) from Opening Last Fall -- Nursing homes, the nidus of COVID-19 death -- The use of universal masking -- Communicating about the impact of surges and quarantines -- Communicating about the adverse effects of the cure -- How we communicate about COVID-19 in other countries -- Other viral pandemics with reference to COVID-19 -- A Path Forward: BRCTs for COVID-19 and Beyond.
650 0 $a Health risk communication. $3 338510
650 0 $a COVID-19 (Disease) $3 877725
650 1 4 $a Intensive / Critical Care Medicine. $3 274888
650 2 4 $a Primary Care Medicine. $3 275823
700 1 $a Rifkin, Erik. $3 712561
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-74521-9
950 $a Medicine (SpringerNature-11650)